Is Profound Medical Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: PROF) stock is to Strong Buy PROF stock.
Out of 2 analysts, 1 (50%) are recommending PROF as a Strong Buy, 1 (50%) are recommending PROF as a Buy, 0 (0%) are recommending PROF as a Hold, 0 (0%) are recommending PROF as a Sell, and 0 (0%) are recommending PROF as a Strong Sell.
What is PROF's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: PROF) forecast ROE is N/A, which is considered weak.
What is PROF's Price Target?
According to 2 Wall Street analysts that have issued a 1 year PROF price target, the average PROF price target is $16.88, with the highest PROF stock price forecast at $18.00 and the lowest PROF stock price forecast at $15.75.
On average, Wall Street analysts predict that Profound Medical's share price could reach $16.88 by May 11, 2024. The average Profound Medical stock price prediction forecasts a potential upside of 65.44% from the current PROF share price of $10.20.
What is PROF's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: PROF) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 0%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.